The company is a clinical-stage T cell-focused biopharmaceutical company. The Company is engaged in the discovery and development of immuno-therapeutics. The Company was established on January 29, 2014. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on March 16, 2021.
Headquarters
2400 Research Boulevard, Suite 250
Brockville, Ontario;
Contact Details: Purchase the NeoImmuneTech. Inc. report to view the information.
Website: http://neoimmunetech.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service